Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.

Autor:	Gospodarczyk AZ; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland., Wojciechowska C; Second Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland., Marczewski KP; Department of Emergency Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Gospodarczyk NJ; Department of Emergency Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Zalejska-Fiolka J; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.
Jazyk:	angličtina
Zdroj:	Medicine [Medicine (Baltimore)] 2022 Dec 09; Vol. 101 (49), pp. e31540.
DOI:	10.1097/MD.0000000000031540
Abstrakt:	The pandemic of coronavirus disease 2019 (COVID-19) has posed a major health challenge for over 2 years. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes it belongs to single-stranded ribonucleic acid viruses and causes acute respiratory distress syndrome. The initial outbreak was discovered in December 2019 in Wuhan province, where SARS-CoV-2 quickly spread to other countries. In addition to respiratory disorders, it has been shown that during and after COVID-19 infection, cardiovascular diseases are often developed or exacerbated, such as: arterial hypertension, coronary artery disease, arrhythmias, heart failure and thromboembolic complications. In view of the higher prevalence of atherosclerosis in patients with COVID-19, we described the pathomechanisms of the development of this infection and the possible correlations between SARS-CoV-2 infection and thromboembolic complications. We focused on the role of the inflammatory response, renin-angiotensin system and endothelial dysfunction in the development of atherosclerosis in patients with COVID-19. A thorough understanding of the hemodynamic mechanisms and the impact of the infection on the cardiovascular system will allow for the proper selection of appropriate therapy in patients after SARS-CoV-2 infection. Competing Interests: The authors have no conflicts of interest to disclose. (Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu